1-6 of 6
Yeong Jer Lim
Close
Sort by
Journal Articles

Deep Immune Profiling Identifies Novel T-Cell Subpopulations That Influence Specific Clinical Outcomes in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Paul Kennedy, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 4626.
https://doi.org/10.1182/blood-2023-185091
Published: 2023
Journal Articles

Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1455.
https://doi.org/10.1182/blood-2023-185063
Published: 2023
Journal Articles

High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1894.
https://doi.org/10.1182/blood-2023-185018
Published: 2023
Journal Articles

Long-Term Safety and Efficacy of Autologous or Allogeneic Donor Stem Cell Transplantation in Patients with Behçet's Syndrome

Amit Patel, MBBS, PhD MRCP(Lond), MRCS(Eng), MAcadMEd, FFICM, FRCPath, Yeong Jer Lim, MBChB, MRCP(UK)
Journal: Blood
Blood (2018) 132 (Supplement 1): 3444.
https://doi.org/10.1182/blood-2018-99-115815
Published: 2018
Journal Articles

Randomized Trials of Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Systematic Review and Meta-Analysis with Trial Sequential Analysis of Overall Mortality

Amit Patel, MBBS, PhD MRCP(Lond), MRCS(Eng), MAcadMEd, FFICM, FRCPath, Yeong Jer Lim, MBChB, MRCP(UK)
Journal: Blood
Blood (2018) 132 (Supplement 1): 612.
https://doi.org/10.1182/blood-2018-99-115326
Published: 2018
Journal Articles

Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival

Nicolas Martinez-Calle, MD #, Edward Poynton, Alia Alchawaf, MD, Shireen Kassam, MD, Matthew Horan, MD, Mark Rafferty, MBBS, BSc, Phillipa Kelsey, MD, Gemma Scott, MD, Stephanie Bruce, MD, Hannah Buckley, MD, Sophie Jones, MD, Yeong Jer Lim, MD, Ngu Loretta, MD, David Lewis, MD, Thankamma Ajithkumar, MD, Dominic J. Culligan, Clare Rowntree, MD, Josh Wright, MD, Pamela McKay, MD, Samih Fourali, MD, Toby A. Eyre, Jeffrey Smith, MD, Wendy Osborne, MD, Deborah Yallop, MBBS FRCP FRCPath PhD, Kim Linton, MBChB PhD, Christopher P. Fox, MD PhD, Kate Cwynarski, MD PhD # (#Shared authorship)
Journal: Blood
Blood (2018) 132 (Supplement 1): 572.
https://doi.org/10.1182/blood-2018-99-111901
Published: 2018